Skip to main content
. 2022 Nov 11;13:966329. doi: 10.3389/fimmu.2022.966329

Figure 3.

Figure 3

Interceptive medicine. The paradigm shift to study complex chronic immune-mediated traits proposed by the LifeTime Initiative and the SYSCID Consortium.